Readygo Diagnostics Unveils Groundbreaking Single Tube Mpox Virus Detection Assay

September 11, 2024 09:00 AM BST | By Pressat
 Readygo Diagnostics Unveils Groundbreaking Single Tube Mpox Virus Detection Assay
Image source: Pressat
Wednesday 11 September, 2024

Bath, UK, September 10, 2024 – ReadyGo Diagnostics Ltd., a leader in rapid diagnostic solutions, proudly announces the development of an innovative single-tube Monkey pox (Mpox) virus detection assay.

This pioneering assay utilizes ReadyGo Diagnostics' cutting-edge expertise in point-of-care testing to address the critical need for swift and precise diagnostics in response to the growing Mpox threat.

The new assay, designed for rapid results in under 20 minutes, integrates seamlessly with ReadyGo's SnapCollect sample collection and processing consumable, known for its efficacy in capturing and processing viruses from saliva. The test can be deployed on ReadyGo's affordable Geo molecular platform or as a standalone kit compatible with traditional laboratory-based molecular platforms. Utilizing Meridian Bioscience Inc.’s Air-Dryable Direct RNA/DNA LAMP Saliva (MDX137) reagents, this assay promises exceptional accuracy and reliability, essential for effective patient isolation and treatment.

“We’re excited to bring this much-needed Mpox detection tool to the market,” said Dr. Ben Cobb, CEO of ReadyGo Diagnostics. “Our innovative approach harnesses the latest advancements in diagnostic technology to meet the urgent needs of healthcare providers worldwide. We have been working with Meridian’s innovative molecular reagents for some time and our combined expertise will bring a much-needed powerful Mpox detection tool to the market”

The Mpox assay is set to undergo rigorous testing to meet international standards and is scheduled to be available in September, 2024. It will be made available to healthcare providers and partners for distribution in cost-sensitive regions that require reliable point-of-care diagnostics. This assay is positioned to become a vital tool in early detection and outbreak management, helping to protect communities worldwide.

Media Contact:
ReadyGo Diagnostics Ltd.
Ben Cobb, CEO
Ben Reed, CCO
Email: [email protected]
www.readygotest.com

About ReadyGo Diagnostics Ltd.:
ReadyGo Diagnostics Ltd. is a leader in the development of innovative rapid diagnostic tests designed to meet the demands of point-of-care settings worldwide. The company’s commitment to advancing healthcare through technology-driven solutions ensures timely and accurate diagnostics for a wide range of infectious diseases.


Distributed by https://pressat.co.uk/


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next